Abstract
Japanese encephalitis (JE) is a viral encephalitis caused by Japanese encephalitis virus (JEV), a single stranded positive sense RNA virus of the genus Flavivirus. The reservoir of JEV is wild birds and pigs; it is spread to humans by mosquitoes. There are approximately 68,000 cases and 15,000 deaths per year. JE is endemic to South and Southeast Asia where 2.5 billion people live. Although most of this population are exposed to JEV, only a minority develop JE. JE is a disease of children and the adult population is immune as a result of childhood exposure. The factors that determine whether or not disease develops relate largely to the host immune response and are still being actively investigated. Patients with JE develop a febrile illness followed by the onset of headache, vomiting, clouding of consciousness and possibly seizures. A wide range of neurological abnormalities are possible; for example focal upper motor neuron lesions, acute flaccid paralysis and extrapyramidal features. There are no proven effective therapies and treatment is supportive; however, JE can be prevented by vaccination. A number of vaccines are available including both live attenuated and inactivated cell culture derived vaccines.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aleyas AG, Han YW, George JA et al (2010) Multifront assault on antigen presentation by Japanese encephalitis virus subverts CD8+ T cell responses. J Immunol 185:1429–1441. doi:10.4049/jimmunol.0902536
Arai S, Matsunaga Y, Takasaki T et al (2008) Japanese encephalitis: surveillance and elimination effort in Japan from 1982 to 2004. Jpn J Infect Dis 61:333–338
Beasley DWC, Lewthwaite P, Solomon T (2008) Current use and development of vaccines for Japanese encephalitis. Expert Opin Biol Ther 8:95–106. doi:10.1517/14712598.8.1.95
Becker H, Desch H, Hacker H, Pencz A (1979) CT fogging effect with ischemic cerebral infarcts. Neuroradiology 18:185–192
Bista MB, Banerjee MK, Shin SH et al (2001) Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study. Lancet 358:791–795
Biswas SM, Ayachit VM, Sapkal GN et al (2009) Japanese encephalitis virus produces a CD4+ Th2 response and associated immunoprotection in an adoptive-transfer murine model. J Gen Virol 90:818–826. doi:10.1099/vir.0.008045-0
Burke DS, Lorsomrudee W, Leake CJ et al (1985a) Fatal outcome in Japanese encephalitis. Am J Trop Med Hyg 34:1203–1210
Burke DS, Nisalak A, Ussery MA et al (1985b) Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. J Infect Dis 151:1093–1099
Campbell G, Hills S, Fischer M et al (2011) Estimated global incidence of Japanese encephalitis. Bull World Health Organ 89:766–774. doi:10.2471/BLT.10.085233
Chambers TJ, Hahn CS, Galler R, Rice CM (1990) Flavivirus genome organization, expression, and replication. Annu Rev Microbiol 44:649–688. doi:10.1146/annurev.mi.44.100190.003245
Chen Y, Maguire T, Hileman RE et al (1997) Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 3:866–871
Das S, Dutta K, Kumawat KL et al (2011) Abrogated inflammatory response promotes neurogenesis in a murine model of Japanese encephalitis. PLoS One 6:e17225. doi:10.1371/journal.pone.0017225.g008
Desai A, Shankar SK, Ravi V et al (1995) Japanese encephalitis virus antigen in the human brain and its topographic distribution. Acta Neuropathol 89:368–373
Desai A, Shankar SK, Jayakumar PN et al (1997) Co-existence of cerebral cysticercosis with Japanese encephalitis: a prognostic modulator. Epidemiol Infect 118:165–171
Dung NM, Turtle L, Chong WK et al (2009) An evaluation of the usefulness of neuroimaging for the diagnosis of Japanese encephalitis. J Neurol 256:2052–2060. doi:10.1007/s00415-009-5249-5
Fujii Y, Kitaura K, Nakamichi K et al (2008) Accumulation of T-cells with selected T-cell receptors in the brains of Japanese encephalitis virus-infected mice. Jpn J Infect Dis 61:40–48
Gatchalian S, Yao Y, Zhou B et al (2008) Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants. Vaccine 26:2234–2241. doi:10.1016/j.vaccine.2008.02.042
German AC, Myint KSA, Mai NTH et al (2006) A preliminary neuropathological study of Japanese encephalitis in humans and a mouse model. Trans R Soc Trop Med Hyg 100:1135–1145. doi:10.1016/j.trstmh.2006.02.008
Glaser CA, Honarmand S, Anderson LJ et al (2006) Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 43:1565–1577. doi:10.1086/509330
Granerod J, Ambrose HE, Davies NW et al (2010) Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 10:835–844. doi:10.1016/S1473-3099(10)70222-X
Handique SK, Das RR, Barman K et al (2006) Temporal lobe involvement in Japanese encephalitis: problems in differential diagnosis. AJNR Am J Neuroradiol 27:1027–1031
Haymaker W, Sabin AB (1947) Topographic distribution of lesions in central nervous system in Japanese B encephalitis; nature of the lesions, with report of a case on Okinawa. Arch Neurol Psychiatry 57:673–692
Hoke C, Nisalak A, Sangawhipa N et al (1988) Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 319:608–614
Hoke CH, Vaughn DW, Nisalak A et al (1992) Effect of high-dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus. J Infect Dis 165:631–637
Huy BV, Tu HC, Luan TV, Lindqvist R (1994) Early mental and neurological sequelae after Japanese B encephalitis. Southeast Asian J Trop Med Public Health 25:549–553
Impoinvil DE, Solomon T, Schluter WW et al (2011) The spatial heterogeneity between Japanese encephalitis incidence distribution and environmental variables in Nepal. PLoS One 6:e22192. doi:10.1371/journal.pone.0022192
Kalita J, Misra UK (2000) Comparison of CT scan and MRI findings in the diagnosis of Japanese encephalitis. J Neurol Sci 174:3–8
Kalita J, Misra UK, Pandey S, Dhole TN (2003) A comparison of clinical and radiological findings in adults and children with Japanese encephalitis. Arch Neurol 60:1760–1764. doi:10.1001/archneur.60.12.1760
Kato H, Takeuchi O, Sato S et al (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101–105. doi:10.1038/nature04734
Kimura-Kuroda J, Yasui K (1988) Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. J Immunol 141:3606–3610
Konishi E, Kurane I, Mason PW et al (1995) Japanese encephalitis virus-specific proliferative responses of human peripheral blood T lymphocytes. Am J Trop Med Hyg 53:278–283
Kumar R, Mathur A, Singh KB et al (1993) Clinical sequelae of Japanese encephalitis in children. Indian J Med Res 97:9–13
Kumar P, Uchil PD, Sulochana P et al (2003) Screening for T cell-eliciting proteins of Japanese encephalitis virus in a healthy JE-endemic human cohort using recombinant baculovirus-infected insect cell preparations. Arch Virol 148:1569–1591. doi:10.1007/s00705-003-0118-5
Kumar P, Krishna VD, Sulochana P et al (2004a) Cell-mediated immune responses in healthy children with a history of subclinical infection with Japanese encephalitis virus: analysis of CD4+ and CD8+ T cell target specificities by intracellular delivery of viral proteins using the human immunodeficiency virus Tat protein transduction domain. J Gen Virol 85:471–482
Kumar P, Sulochana P, Nirmala G et al (2004b) Impaired T helper 1 function of nonstructural protein 3-specific T cells in Japanese patients with encephalitis with neurological sequelae. J Infect Dis 189:880–891. doi:10.1086/381768
Kumar P, Sulochana P, Nirmala G et al (2004c) Conserved amino acids 193-324 of non-structural protein 3 are a dominant source of peptide determinants for CD4+ and CD8+ T cells in a healthy Japanese encephalitis virus-endemic cohort. J Gen Virol 85:1131–1143
Kumar R, Tripathi P, Baranwal M et al (2009a) Randomized, controlled trial of oral ribavirin for Japanese encephalitis in children in Uttar Pradesh, India. Clin Infect Dis 48:400–406. doi:10.1086/596309
Kumar R, Tripathi P, Rizvi A (2009b) Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis. N Engl J Med 360:1465–1466. doi:10.1056/NEJMc0808664
Larena M, Regner M, Lee E, Lobigs M (2011) Pivotal role of antibody and subsidiary contribution of CD8+ T Cells to recovery from infection in a murine model of Japanese encephalitis. J Virol 85:5446–5455. doi:10.1128/JVI.02611-10
Le Van Tan P, Do Quang Ha N, Lam Quoi Bao B et al (2010) Viral etiology of encephalitis in children in southern Vietnam: results of a one-year prospective descriptive study. PLoS Negl Trop Dis 4(10):e854
Leake CJ, Burke DS, Nisalak A, Hoke CH (1986) Isolation of Japanese encephalitis virus from clinical specimens using a continuous mosquito cell line. Am J Trop Med Hyg 35:1045–1050
Lewthwaite P, Begum A, Ooi MH et al (2010a) Disability after encephalitis: development and validation of a new outcome score. Bull World Health Organ 88:584–592. doi:10.2471/BLT.09.071357
Lewthwaite P, Shankar MV, Tio PH et al (2010b) Evaluation of two commercially available ELISAs for the diagnosis of Japanese encephalitis applied to field samples. Trop Med Int Health 15:811–818. doi:10.1111/j.1365-3156.2010.02537.x
Li J-K, Liang J-J, Liao C-L, Lin Y-L (2012) Autophagy is involved in the early step of Japanese encephalitis virus infection. Microbes Infect 14:159–168. doi:10.1016/j.micinf.2011.09.001
Libraty DH, Nisalak A, Endy TP et al (2002) Clinical and immunological risk factors for severe disease in Japanese encephalitis. Trans R Soc Trop Med Hyg 96:173–178
Lin R-J, Liao C-L, Lin E, Lin Y-L (2004) Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection. J Virol 78:9285–9294. doi:10.1128/JVI.78.17.9285-9294.2004
Lin R-J, Chang B-L, Yu H-P et al (2006) Blocking of interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism. J Virol 80:5908–5918. doi:10.1128/JVI.02714-05
Lindenbach BD, Thiel H-J, Rice CM (2007) Flaviviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology. Lippincott Williams and Wilkins, Philadelphia, PA
Liu ZL, Hennessy S, Strom BL et al (1997) Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects. J Infect Dis 176:1366–1369
Lubiniecki AS, Cypess RH, Hammon WM (1973) Passive immunity for arbovirus infection. II. Quantitative aspects of naturally and artificially acquired protection in mice for Japanese (B) encephalitis virus. Am J Trop Med Hyg 22:535–542
Mathur A, Arora KL, Chaturvedi UC (1983) Host defence mechanisms against Japanese encephalitis virus infection in mice. J Gen Virol 64(Pt 4):805–811
Melian EB, Hinzman E, Nagasaki T et al (2010) NS1′ of flaviviruses in the Japanese encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in viral neuroinvasiveness. J Virol 84:1641–1647. doi:10.1128/JVI.01979-09
Mishra MK, Basu A (2008) Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis. J Neurochem 105:1582–1595. doi:10.1111/j.1471-4159.2008.05238.x
Miyake M (1964) The pathology of Japanese encephalitis. A review. Bull World Health Organ 30:153–160
Mogi M (1983) Relationship between number of human Japanese encephalitis cases and summer meteorological conditions in Nagasaki, Japan. Am J Trop Med Hyg 32:170–174
Mukhopadhyay S, Kuhn RJ, Rossmann MG (2005) A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 3:13–22. doi:10.1038/nrmicro1067
Murali-Krishna K, Ravi V, Manjunath R (1996) Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitis virus by adoptively transferred virus-specific cytotoxic T lymphocytes: requirement for L3T4+ T cells. J Gen Virol 77(Pt 4):705–714
Murty US, Rao MS, Arunachalam N (2010) The effects of climatic factors on the distribution and abundance of Japanese encephalitis vectors in Kurnool district of Andhra Pradesh, India. J Vector Borne Dis 47:26–32
Ohrr H, Tandan JB, Sohn YM et al (2005) Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study. Lancet 366:1375–1378. doi:10.1016/S0140-6736(05)67567-8
Pyrgos V, Younus F (2004) High-dose steroids in the management of acute flaccid paralysis due to West Nile virus infection. Scand J Infect Dis 36:509–512
Ravi V, Desai A, Balaji M et al (2006) Development and evaluation of a rapid IgM capture ELISA (JEV-Chex) for the diagnosis of Japanese encephalitis. J Clin Virol 35:429–434. doi:10.1016/j.jcv.2005.11.004
Ravi V, Robinson JS, Russell BJ et al (2009) Evaluation of IgM antibody capture enzyme-linked immunosorbent assay kits for detection of IgM against Japanese encephalitis virus in cerebrospinal fluid samples. Am J Trop Med Hyg 81:1144–1150. doi:10.4269/ajtmh.2009.09-0144
Richter RW, Shimojyo S (1961) Neurologic sequelae of Japanese B encephalitis. Neurology 11:553–559
Sapkal GN, Wairagkar NS, Ayachit VM et al (2007) Detection and isolation of Japanese encephalitis virus from blood clots collected during the acute phase of infection. Am J Trop Med Hyg 77:1139–1145
Solomon T (2000) In: Gilman S (ed) MedLink neurology. Medlink Corporation, Japanese Encephalitis. San Diego, CA. http://www.medlink.com
Solomon T (2004a) Encephalitis. In: Gill GV, Beeching N (eds) Lecture notes: tropical medicine, 5th edn. Wiley-Blackwell, Oxford
Solomon T (2004b) Flavivirus encephalitis. N Engl J Med 351:370–378. doi:10.1056/NEJMra030476
Solomon T (2006) Control of Japanese encephalitis – within our grasp? N Engl J Med 355:869–871. doi:10.1056/NEJMp058263
Solomon T (2008) New vaccines for Japanese encephalitis. Lancet Neurol 7:116–118. doi:10.1016/S1474-4422(08)70004-8
Solomon T, Winter PM (2004) Neurovirulence and host factors in flavivirus encephalitis – evidence from clinical epidemiology. Arch Virol Suppl (18):161–170
Solomon T, Kneen R, Dung NM et al (1998a) Poliomyelitis-like illness due to Japanese encephalitis virus. Lancet 351:1094–1097. doi:10.1016/S0140-6736(97)07509-0
Solomon T, Thao LT, Dung NM et al (1998b) Rapid diagnosis of Japanese encephalitis by using an immunoglobulin M dot enzyme immunoassay. J Clin Microbiol 36:2030–2034
Solomon T, Dung NM, Kneen R et al (2000) Japanese encephalitis. J Neurol Neurosurg Psychiatr 68:405–415
Solomon T, Dung NM, Kneen R et al (2002) Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis. Brain 125:1084–1093
Solomon T, Dung NM, Wills B et al (2003a) Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial. Lancet 361:821–826
Solomon T, Ni H, Beasley DWC et al (2003b) Origin and evolution of Japanese encephalitis virus in southeast Asia. J Virol 77:3091–3098
Solomon T, Thao TT, Lewthwaite P et al (2008) A cohort study to assess the new WHO Japanese encephalitis surveillance standards. Bull World Health Organ 86:178–186
Sumiyoshi H, Mori C, Fuke I et al (1987) Complete nucleotide sequence of the Japanese encephalitis virus genome RNA. Virology 161:497–510
Swami R, Ratho RK, Mishra B, Singh MP (2008) Usefulness of RT-PCR for the diagnosis of Japanese encephalitis in clinical samples. Scand J Infect Dis 40:815–820. doi:10.1080/00365540802227102
Tauber E, Kollaritsch H, Korinek M et al (2007) Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial. Lancet 370:1847–1853. doi:10.1016/S0140-6736(07)61780-2
Torresi J, McCarthy K, Feroldi E, Méric C (2010) Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: randomised controlled phase 3 trials. Vaccine 28:7993–8000. doi:10.1016/j.vaccine.2010.09.035
Turtle L, Griffiths MJ, Solomon T (2012) Encephalitis caused by flaviviruses. QJM 105:219–223. doi:10.1093/qjmed/hcs013
Uchil PD, Satchidanandam V (2003) Architecture of the flaviviral replication complex. Protease, nuclease, and detergents reveal encasement within double-layered membrane compartments. J Biol Chem 278:24388–24398. doi:10.1074/jbc.M301717200
Van Den Hurk AF, Montgomery BL, Northill JA et al (2006) Short report: the first isolation of Japanese encephalitis virus from mosquitoes collected from mainland Australia. Am J Trop Med Hyg 75:21–25
Wang K, Deubel V (2011) Mice with different susceptibility to Japanese encephalitis virus infection show selective neutralizing antibody response and myeloid cell infectivity. PLoS One 6:e24744. doi:10.1371/journal.pone.0024744
Wang T, Town T, Alexopoulou L et al (2004) Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10:1366–1373. doi:10.1038/nm1140
Winter PM, Dung NM, Loan HT et al (2004) Proinflammatory cytokines and chemokines in humans with Japanese encephalitis. J Infect Dis 190:1618–1626. doi:10.1086/423328
World Health Organisation (2004) WHO world health report 2004, pp 1–96
World Health Organisation (2005) WER/GACVS June 2005 JE vaccine safety. Wkly Epidemiol Rec 80:241–248
World Health Organisation (2006) WER/2006 JE vaccine position statement. Wkly Epidemiol Rec 81:325–340
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Basel
About this chapter
Cite this chapter
Turtle, L., Solomon, T. (2013). Japanese Encephalitis Virus Infection. In: Jackson, A. (eds) Viral Infections of the Human Nervous System. Birkhäuser Advances in Infectious Diseases. Springer, Basel. https://doi.org/10.1007/978-3-0348-0425-7_11
Download citation
DOI: https://doi.org/10.1007/978-3-0348-0425-7_11
Published:
Publisher Name: Springer, Basel
Print ISBN: 978-3-0348-0424-0
Online ISBN: 978-3-0348-0425-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)